Statistics for Challenging the catechism of therapeutics for chronic neuropathic pain: targeting CaV2.2 interactions with CRMP2 peptides
Total visits
views | |
---|---|
Challenging the catechism of therapeutics for chronic neuropathic pain: targeting CaV2.2 interactions with CRMP2 peptides | 303 |
Total visits per month
views | |
---|---|
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
File Visits
views | |
---|---|
nihms-502449.pdf | 765 |
java.util.UUID:36bbfa9b-78bd-42c8-bc55-b79a44c8bba7 | 131 |
java.util.UUID:63a861bf-1b97-4b95-8e68-e0b910303c76 | 10 |
java.util.UUID:12d3b84a-4ed8-4bc6-b490-031b8b4757b5 | 5 |
Top country views
views | |
---|---|
United States | 215 |
Germany | 19 |
United Kingdom | 6 |
Poland | 6 |
Ukraine | 5 |
Russia | 4 |
Sweden | 4 |
Canada | 3 |
Italy | 2 |
Austria | 1 |
Belgium | 1 |
France | 1 |
India | 1 |
Malaysia | 1 |
Taiwan | 1 |
Top city views
views | |
---|---|
Wilmington | 59 |
Fairfield | 36 |
Ann Arbor | 18 |
Houston | 15 |
Kiez | 14 |
Cambridge | 13 |
Jacksonville | 7 |
San Francisco | 7 |
Kiev | 5 |
Kraków | 4 |
Lake Mary | 4 |
Philadelphia | 4 |
Stockholm | 4 |
White Plains | 4 |
Munich | 3 |
Saint Petersburg | 3 |
Baltimore | 2 |
Chicago | 2 |
Concord | 2 |
Elblag | 2 |
Gunzenhausen | 2 |
Mountain View | 2 |
Norwich | 2 |
Toronto | 2 |
Warrington | 2 |
Washington | 2 |
Alexandria | 1 |
Brooklyn | 1 |
Falls Church | 1 |
Grùmolo | 1 |
Indianapolis | 1 |
Irvine | 1 |
Milan | 1 |
Moscow | 1 |
Nanterre | 1 |
Newark | 1 |
Norwalk | 1 |
Scottsdale | 1 |
Seremban | 1 |
Taipei | 1 |
Vienna | 1 |
Winnipeg | 1 |
Zaventem | 1 |